Eritrea vs Yemen: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Eritrea
0.5%
in 2024
Yemen
0.5%
in 2024
Eritrea rank
56th
Yemen rank
56th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Eritrea
- Yemen
How they compare
Eritrea currently reports 0.5% against 0.5% in Yemen, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Yemen ahead.
Eritrea ranks 56th and Yemen ranks 56th of 215 countries.
Across the 2 decades both report, Eritrea averaged higher in 1 and Yemen in 1.
Head to head by decade
| Decade | Eritrea | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.6% | 0.6% | 0.0% | Yemen |
| 2020s | 0.6% | 0.5% | 0.0% | Eritrea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Eritrea or Yemen?
- Eritrea, at 0.5% against 0.5% in Yemen as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Eritrea and Yemen?
- 0.0%, with Eritrea ahead.
- How many years of comparable data are there for Eritrea and Yemen?
- 10 years are reported by both, from 2015 to 2024.
- How do Eritrea and Yemen rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Eritrea ranks 56th and Yemen ranks 56th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.